Clinical significance of alanine aminotransferase levels and the effect of ursodeoxycholic acid in hemodialysis patients with chronic hepatitis C
Authors:
- 5 November 2009
- journal article
- Published by Springer Nature in Journal of Gastroenterology
- Vol. 45 (3) , 326-334
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Treatment of hepatitis C in hemodialysis patients using pegylated interferon α-2a in TurkeyJournal of Gastroenterology, 2009
- A large-scale, multicentre, double-blind trial of ursodeoxycholic acid in patients with chronic hepatitis CGut, 2007
- Alanine aminotransferase level as a predictor of hepatitis C virus‐associated hepatocellular carcinoma incidence in a community‐based population in JapanInternational Journal of Cancer, 2006
- Meta‐analysis: effect of hepatitis C virus infection on mortality in dialysisAlimentary Pharmacology & Therapeutics, 2004
- Special Article: National Surveillance of Dialysis‐Associated Diseases in the United States, 2001Seminars in Dialysis, 2004
- A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis CHepatology, 2003
- The Current State of Chronic Dialysis Treatment in Japan(as of December 31, 2000)1Therapeutic Apheresis and Dialysis, 2003
- The tolerance and efficacy of interferon‐α in haemodialysis patients with HCV infection: a multicentre, prospective studyNephrology Dialysis Transplantation, 2001
- Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levelsHepatology, 1997
- Hepatitis C virus: The nephrologist's viewAmerican Journal of Kidney Diseases, 1995